Slash Medical Fentanyl Test Cartridge – FDA/CLIA Waived

Fentanyl Cartridge Test from Slash Medical:

• Trusted by healthcare professionals for timely intervention and patient care.
• Easy-to-use design facilitates swift testing and interpretation.
• FDA-approved for utmost confidence in every diagnosis.

Swiftly detects fentanyl presence with unparalleled accuracy.

Remarkable cutoff sensitivity of 1ng/ml for precise results.

Fentanyl Cartridge Test Instructions for Use:

1. 1. Ensure that the test kit, urine sample, and/or controls are brought to room temperature (59-86ºF or 15-30ºC) before conducting the test.
   2. Take out the test cassette from its sealed pouch and utilize it within one hour.
   3. Position the test cassette on a clean, flat surface. Hold the dropper vertically and dispense 3 full drops of urine (approximately 120 μL) into the specimen well (S) of the test cassette. Start the timer. Make sure not to trap air bubbles in the specimen well.
   4. Allow time for colored lines to develop. Interpret the results at the 5-minute mark. Results should not be interpreted after 10 minutes.

The advantage of an FDA-approved and CLIA-waived Fentanyl Cartridge test lies in its reliability, accuracy, and ease of use.

FDA Approval: FDA approval ensures that the test has undergone rigorous testing to confirm its effectiveness and safety for detecting fentanyl. This gives users confidence in the test’s reliability and accuracy.

CLIA Waived: CLIA (Clinical Laboratory Improvement Amendments) waived status indicates that the test is simple and safe enough to be performed outside of a traditional laboratory setting by personnel who may not have extensive laboratory training. This makes it accessible to a wider range of healthcare providers and allows for quicker and more convenient testing, especially in settings such as doctors’ offices, clinics, or even at home.

Accuracy: With FDA approval and CLIA waiver, users can trust that the test provides accurate results, helping healthcare providers make informed decisions about patient care quickly and efficiently.

Convenience: The combination of FDA approval and CLIA waiver means that the test can be easily incorporated into routine medical practice without the need for specialized equipment or extensive training. This enhances the convenience of testing for both healthcare providers and patients.

Overall, the advantage of an FDA-approved and CLIA-waived Fentanyl Cartridge test lies in its credibility, accessibility, accuracy, and convenience, all of which contribute to improved patient care and outcomes.